PhaseRx, Inc./ US71723F1030 /

6/27/2022 3:30:20 PM	Chg. -	Volume	Bid-	Ask-	High	Low
0.0002USD	-	100 Turnover: .0200	-Bid Size: -	-Ask Size: -	0.0002	0.0002

GlobeNewswire 8/16/2018 HTG Molecular Appoints Michelle R. Griffin to its Board of Directors

GlobeNewswire 8/13/2018 Gene Therapy Market, 2018-2030 - Around 300 Product Candidates Under Various Stages of Development f...

GlobeNewswire 5/16/2018 Gene Therapy Market, 2030

GlobeNewswire 4/18/2018 Delisting of Securities of Rex Energy Corporation, PhaseRx, Inc., Stanley Furniture Company, Inc., a...

GlobeNewswire 2/21/2018 Global Healthcare Attorney Hourly Rate Report 2018: Hourly Rates of Attorneys, Partners, Counsel, Se...

GlobeNewswire 11/15/2017 Two Report Package: Immunotherapy with Oncolytic Viruses and mRNA Vaccines & Therapeutics

GlobeNewswire 11/2/2017 Analysis: Positioning to Benefit within Tandem Diabetes Care, CASI Pharmaceuticals, SAExploration, R...

GlobeNewswire 10/12/2017 Acer Therapeutics Welcomes Two New Members to its Board of Directors

GlobeNewswire 8/10/2017 Global mRNA Vaccines & Therapeutics Markets 2017: Industry Analysis of Technologies, Pipelines, Stak...

GlobeNewswire 7/20/2017 Global RNAi Technology Report 2017: Insect and Pest Control, Disease and Weed Control, Crop Enhancem...